BioWorld

May 12, 2006

View Archived Issues

Avigen Adds $21M Privately To Focus On Neurology Products

With plans to expand the scope of its existing development programs, Avigen Inc. is raising $21.2 million through a private placement to institutional investors. (BioWorld Today) Read More

Genzyme, Angiotech Partner On Localized Cancer Therapy

Read More

New Models Hopefully Spell End Of One-Size-Fits-All Era

Read More

Diatos In-licensing Gilead's Kaposi's Drug DaunoXome

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Appointments And Advancements

Read More